Albert Pérez-Martí

Albert Pérez-Martí

Auto-generated profile, based on publicly available information

Albert Pérez-Martí

Section Nephrogenetics, Institute of Human Genetics, University Hospital Heidelberg

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2013 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
ASAna Luísa De Sousa-Coelho
Ana Luísa De Sousa-Coelho
Joana RelatJoana Relat
Joana Relat
EHElayne Hondares
Elayne Hondares
APAlbert Pérez-Martí
Albert Pérez-Martí
FRFrancesc Ribas-Aulinas
Francesc Ribas-Aulinas
Diego HaroDiego Haro
Diego Haro
Ana Luísa De Sousa-Coelho, Joana Relat, Elayne Hondares, Albert Pérez-Martí, Francesc Ribas, Francesc Villarroya, Pedro F. Marrero, Diego Haro

11 January 2017 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
APAlbert Pérez‐Martí
Albert Pérez‐Martí
MGMaite Garcia‐Guasch
Maite Garcia‐Guasch
ATAnna Tresserra-Rimbau
Anna Tresserra-Rimbau
ACAlexandra Carrilho‐Do‐Rosário
Alexandra Carrilho‐Do‐Rosário
RERamon Estruch
Ramon Estruch
Joana RelatJoana Relat
Joana Relat

12 May 2022 in eLife
Verified
Journal Article
Open access
APAlbert Pérez-Martí
Albert Pérez-Martí
SRSuresh Ramakrishnan
Suresh Ramakrishnan
JLJiayi Li
Jiayi Li
ADAurelien Dugourd
Aurelien Dugourd
MMMartijn R. Molenaar
Martijn R. Molenaar
MSMatias Simons
Matias Simons
In diabetic patients, dyslipidemia frequently contributes to organ damage such as diabetic kidney disease (DKD). Dyslipidemia is associated with both excessive deposition of triacylglycerol (TAG) in lipid droplets (LDs) and lipotoxicity. Yet, it is unclear how these two effects correlate with each other in the kidney and how they are influenced by dietary patterns. By using a diabetes mouse model, we find here that high-fat diet enriched in the monounsaturated oleic acid (OA) caused more lipid storage in LDs in renal proximal tubular cells (PTCs) but less tubular damage than a corresponding butter diet with the saturated palmitic acid (PA). This effect was particularly evident in S2/S3 but not S1 segments of the proximal tubule. Combining transcriptomics, lipidomics, and functional studies, we identify endoplasmic reticulum (ER) stress as the main cause of PA-induced PTC injury. Mechanistically, ER stress is caused by elevated levels of saturated TAG precursors, reduced LD formation, and, consequently, higher membrane order in the ER. Simultaneous addition of OA rescues the cytotoxic effects by normalizing membrane order and increasing both TAG and LD formation. Our study thus emphasizes the importance of monounsaturated fatty acids for the dietary management of DKD by preventing lipid bilayer stress in the ER and promoting TAG and LD formation in PTCs.

20 June 2016 in Hormone Molecular Biology and Clinical Investigation
Verified
Journal Article
Closed access
PDF file
APAlbert Pérez-Martí
Albert Pérez-Martí
VSViviana Sandoval
Viviana Sandoval
PMPedro F. Marrero
Pedro F. Marrero
Diego HaroDiego Haro
Diego Haro
Joana RelatJoana Relat
Joana Relat
Obesity is a worldwide health problem mainly due to its associated comorbidities. Fibroblast growth factor 21 (FGF21) is a peptide hormone involved in metabolic homeostasis in healthy individuals and considered a promising therapeutic candidate for the treatment of obesity. FGF21 is predominantly produced by the liver but also by other tissues, such as white adipose tissue (WAT), brown adipose tissue (BAT), skeletal muscle, and pancreas in response to different stimuli such as cold and different nutritional challenges that include fasting, high-fat diets (HFDs), ketogenic diets, some amino acid-deficient diets, low protein diets, high carbohydrate diets or specific dietary bioactive compounds. Its target tissues are essentially WAT, BAT, skeletal muscle, heart and brain. The effects of FGF21 in extra hepatic tissues occur through the fibroblast growth factor receptor (FGFR)-1c together with the co-receptor β-klotho (KLB). Mechanistically, FGF21 interacts directly with the extracellular domain of the membrane bound cofactor KLB in the FGF21- KLB-FGFR complex to activate FGFR substrate 2α and ERK1/2 phosphorylation. Mice lacking KLB are resistant to both acute and chronic effects of FGF21. Moreover, the acute insulin sensitizing effects of FGF21 are also absent in mice with specific deletion of adipose KLB or FGFR1. Most of the data show that pharmacological administration of FGF21 has metabolic beneficial effects. The objective of this review is to compile existing information about the mechanisms that could allow the control of endogenous FGF21 levels in order to obtain the beneficial metabolic effects of FGF21 by inducing its production instead of doing it by pharmacological administration.

1 July 2012 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MGMar Gacias
Mar Gacias
APAlbert Pérez-Martí
Albert Pérez-Martí
MPMagdalena Pujol-Vidal
Magdalena Pujol-Vidal
PMPedro F. Marrero
Pedro F. Marrero
DHDiego Haro
Diego Haro
Joana RelatJoana Relat
Joana Relat

Verified
Journal Article
Open access
PDF file
DTDaniel Torres-Oteros
Daniel Torres-Oteros
MLMariano Nicola Llorente
Mariano Nicola Llorente
HLHector Sanz Lamora
Hector Sanz Lamora
APAlbert Pérez-Martí
Albert Pérez-Martí
PMPedro Marrero
Pedro Marrero
Joana RelatJoana Relat
Joana Relat
Fibroblast growth factor 21 (FGF21) is a key hormone for metabolic homeostasis under conditions such as obesity, aging and diabetes. While extensively studied in males, its role in female physiology remains poorly defined. This study evaluated the effects of hepatic FGF21 deletion in 12-month-old female mice using a liver-specific FGF21 knockout (FKO) model. FKO females exhibited reduced body weight and improved glucose tolerance, with no changes in circulating FGF21 levels. In the liver, RT-qPCR analysis showed that the expression of genes involved in de novo lipogenesis, including Srebp1c, Fasn, and Scd1, was downregulated, whereas markers of fatty acid uptake (Cd36) and β-oxidation (Cpt1a) were upregulated without alterations in hepatic triglyceride content and lower levels of serum adiponectin. Remarkably, telomere length in both liver and adipose tissue was preserved, indicating improved cellular aging. Hepatic transcriptomic analysis revealed a global downregulation of genes linked to cytoskeletal organization, immune processes and fibrosis. Among these, Chrna4, a hepatocyte-specific nicotinic acetylcholine receptor subunit implicated in protection against metabolic-associated steatohepatitis (MASH), was significantly reduced. These findings suggest that hepatic FGF21 deficiency in aged female mice promotes metabolic health by limiting pro-inflammatory and fibrotic pathways and preserving telomere integrity, with Chrna4 emerging as a potential mediator.